← All indications
Temporomandibular Joint Dysfunction Syndrome
A symptom complex consisting of pain, muscle tenderness, clicking in the joint, and limitation or alteration of mandibular movement. The symptoms are subjective and manifested primarily in the masticatory muscles rather than the temporomandibular joint itself. Etiologic factors are uncertain but include occlusal dysharmony and psychophysiologic factors.
Drugs by status
Phase 2 trials (2)
Phase 1 trials (1)
Other trials (2)
Organizations
Organization Involved with Phase 4 Indications (12)
Organization Involved with Phase 3 Indications (5)
Organization Involved with Phase 2 Indications (20)
- Spherium Biomed
- National Institutes of Health (NIH)
- National Center for Complementary and Integrative Health (NCCIH)
- National Institute of Dental and Craniofacial Research (NIDCR)
- University of Arizona
- Alexandria University
- Duke University
- University of Washington
- Johns Hopkins University
- Universitat Internacional de Catalunya
- University of Florida
- University of Maryland
- University of Tehran
- University of Valencia
- Universidad Rey Juan Carlos
- Pomeranian Medical University
- University of North Carolina at Chapel Hill
- State University of New York, Buffalo
- Rho, Inc.
- Soleno Therapeutics, Inc.
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (10)
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- University of Roma La Sapienza
- Aarhus University
- Instituto Brasileiro de Osteopatia
- University of California, San Francisco
- University of Ankara
- The University of Hong Kong
- American Pain Society
- Alabama Physical Therapy & Acupuncture
- American Academy of Manipulative Therapy